中枢神经系统药物 SCIE

期刊简介估计审稿时候： 较慢,6-12周

CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes:

- Overviews of contentious or emerging issues.

- Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses.

- Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.

- Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry.

- Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in CNS Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

CNS Drugs 努力于增进临床精力病学和精力病学学科内的公道药物医治。该期刊包含：

- 有争议或新兴题目的概述。

- 周全的论述性批评，供给有关医治神经和精力疾病的药理学体例的权势巨子信息来历。

- 系统评估，利用 PRISMA 申明概述的明白、系统体例，汇总经历证据以回覆特定的研讨题目。

- Adis 药物批评，先容精力病学和精力病学中新药和成熟药物的特征和医治地位。

- 首创研讨文章，报告经心设想的研讨功效，与临床理论紧密亲密相干，比方临床药效学和药代能源学研讨、临床实验、聚集阐发、功效研讨和药物经济学和药物风行病学研讨。

其余数字功效（包含动画择要、视频择要、幻灯片、音频幻灯片、讲授视频、信息图表、播客和动画（英语：Animals）可以或许与文章一路颁发；这些旨在进步期刊内容的可见性、读者群和教导代价。另外，在 CNS Drugs 上颁发的文章可以或许会附有浅显易懂的择要，以赞助对该范畴有一定领会但不具备深切专业常识的读者领会主要的医学停顿。

《Cns Drugs》(中枢神经系统药物)编辑部通信体例为ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。